Group One Trading’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Group One Trading’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,666	Closed	-$462K	–	8333
2023 Q4	$481K	Buy	12,666 +11,066	+692%	+$237K	﹤0.01%	3105
2023 Q3	$29.4K	Buy	1,600 +1,003	+168%	+$21K	﹤0.01%	5564
2023 Q2	$15.5K	Buy	+597	New	+$13.9K	﹤0.01%	6147
2022 Q1	–	Sell	-17	Closed	-$1K	–	9232
2021 Q4	$1K	Buy	+17	New	+$680	﹤0.01%	8097

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's INBX Position: Q1 2024 in Review

Group One Trading sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 12,666 shares — an estimated $462K sold.

Group One Trading first reported a position in INBX in Q4 2021 and held it in 4 quarters. The position peaked at $481K in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

Group One Trading reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 12,666 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $462K.
Group One Trading first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Group One Trading's Inhibrx, Inc. Common Stock position peaked at $481K in Q4 2023.
126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.